Search results
24 sty 2022 · A new study found that part of the Epstein-Barr virus mimics a protein made in the brain and spinal cord, leading the immune system to mistakenly attack the body’s nerve cells.
23 lis 2022 · IN JANUARY 2022, Bjornevik and colleagues published the results of a 20-year prospective seroepidemiologic study on the relationship between Epstein-Barr virus (EBV) and multiple sclerosis (MS) in which investigators observed an enormous increase in the risk of MS after EBV infection.
7 lut 2023 · Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
15 lut 2024 · One research consistently identified that active EBV infection in B cells infiltrates MS patients' brains with secondary progressive or acute disease (nearly in all patients). 7 EBV-directed bystander damage may be associated with the progression of MS.
9 lut 2023 · In the first approach, monoclonal antibodies (mAbs) to CD20 are used to kill B cells that harbour latent EBV infection; such mAbs have been approved to treat patients with MS. Targeting of...
The central role of Epstein-Barr virus in causing multiple sclerosis is examined to understand how it triggers the disease and presents new opportunities for treatment.
22 wrz 2023 · Recent evidence strongly implicates infection by the Epstein-Barr virus (EBV) as the trigger for development of multiple sclerosis (MS). An international research team is now gathering to unveil the role of EBV in the onset and progression of the MS disease.
